EX-99.3 4 g17720exv99w3.htm EX-99.3 EX-99.3
Exhibit 99.3
FINANCIAL GUIDANCE SUMMARY
HLTH CORPORATION
2009 Preliminary Financial Guidance

(in millions, except per share amounts)
                 
    Year Ending  
    December 31, 2009  
    Range  
 
               
Revenue
  $ 420.0     $ 450.0  
 
           
 
               
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a)
               
WebMD
  $ 107.0     $ 122.0  
Corporate
    (15.0 )     (14.0 )
 
           
 
  $ 92.0     $ 108.0  
 
               
Adjusted EBITDA per diluted common share
  $ 0.85     $ 1.00  
 
           
 
               
Interest, taxes, non-cash and other items (b)
               
Interest income
    9.0       10.0  
Interest expense (c)
    (18.5 )     (18.5 )
Depreciation and amortization
    (34.0 )     (31.0 )
Minority interest in WHC
    (5.0 )     (7.0 )
Non-cash advertising
    (1.5 )     (1.5 )
Non-cash stock-based compensation
    (39.0 )     (35.0 )
Income tax provision (d)
    (1.2 )     (10.3 )
 
           
 
               
Income from continuing operations
  $ 1.8     $ 14.7  
 
           
 
               
Income from continuing operations per common share:
               
Basic
  $ 0.02     $ 0.14  
 
           
Diluted
  $ 0.02     $ 0.14  
 
           
 
               
Weighted-average shares outstanding used in computing income from continuing operations per common share:
               
Basic
    103.0       103.0  
Diluted
    108.0       108.0  
 
(a)   See Annex A — Explanation of Non-GAAP Financial Measures.
 
(b)   Reconciliation of Adjusted EBITDA to income from continuing operations.
 
(c)   Interest expense does not consider any additional non-cash interest expense that may result from the January 1, 2009 adoption of APB Opinion No. 14-1, “Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion.”
 
(d)   Income tax rate for 2009 is forecasted to be approximately 41% of pretax income from continuing operations. The income tax provision excludes any benefit relating to any reversal in 2009 of the valuation allowance against deferred tax assets.